Candriam Equities L Oncology Impact I Fonds
1.941,92
EUR
-14,22
EUR
-0,73
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Eli Lilly and Co | US5324571083 | 5,44% |
| AstraZeneca PLC | GB0009895292 | 5,03% |
| Siemens Healthineers AG Registered Shares | DE000SHL1006 | 5,03% |
| Merck & Co Inc | US58933Y1055 | 4,92% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 4,62% |
| Amgen Inc | US0311621009 | 4,46% |
| Roche Holding AG | CH0012032048 | 4,39% |
| Novartis AG Registered Shares | CH0012005267 | 4,00% |
| Novo Nordisk AS Class B | DK0062498333 | 3,95% |
| Hologic Inc | US4364401012 | 3,70% |
| Sonstige | 54,45% |